Clinical Efficacy and Long-term Outcomes of ALLOgraft Versus Stented Biological Prosthesis for Primary TRIcuspid Valve Disease (ALLOTRI)

RecruitingOBSERVATIONAL
Enrollment

56

Participants

Timeline

Start Date

January 14, 2016

Primary Completion Date

December 14, 2024

Study Completion Date

June 14, 2025

Conditions
AllograftBioprosthesisTricuspid Valve Disease
Interventions
PROCEDURE

tricuspid valve replacement

Complete or partial tricuspid valve replacement with mitral allograft/ complete tricuspid valve replacement with biological prosthesis

Trial Locations (1)

Unknown

RECRUITING

Department of Cardiac Surgery, Chelyabinsk

All Listed Sponsors
lead

Chelyabinsk Regional Clinical Hospital

OTHER_GOV